Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort

References

• Meucci G. What is the incidence, prevalence, and natural history of indeterminate colitis? Inflamm Bowel Dis 2008;14:S159–60.
   PubMed Web of Science ®Google Scholar
• Tremaine WJ. Diagnosis and treatment of indeterminate colitis. Gastroenterol Hepatol (N Y) 2011;7:826–8.
   PubMedGoogle Scholar
• Guindi M, Riddell RH. Indeterminate colitis. J Clin Pathol 2004;57:1233–44.
   PubMed Web of Science ®Google Scholar
• Scharl M, Rogler G. Inflammatory bowel disease pathogenesis: what is new? Curr Opin Gastroenterol 2012;28:301–9.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Fortinsky KJ, Gozdyra P, Van den HM, Van LJ, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423–39.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.
   PubMed Web of Science ®Google Scholar
• Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013;7:322–37.
   PubMed Web of Science ®Google Scholar
• Jussila A, Virta LJ, Salomaa V, Maki J, Jula A, Farkkila MA. High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. J Crohns Colitis 2013;7:e256–62.
   PubMedGoogle Scholar
• Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 2013;58:519–25.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1792–9.
   PubMed Web of Science ®Google Scholar
• Brandes JW, Lorenz-Meyer H. [Epidemiologic aspects of Crohn regional enterocolitis and ulcerative colitis in Marburg/Lahn (West Germany) between 1962 and 1975]. Z Gastroenterol 1983;21:69–78.
   PubMedGoogle Scholar
• Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol Suppl 1989;170:39–43.
   PubMedGoogle Scholar
• Dirks E, Forster S, Thom M, Quebe-Fehling E. Goebell H. [Prospective study of the incidence and prevalence of ulcerative colitis in a large urban population in Germany (western Ruhr area)]. Z Gastroenterol 1994;32:332–7.
   PubMed Web of Science ®Google Scholar
• Goebell H, Dirks E, Förster S, Strey B, Quebe-Fehling E. A prospective analysis of the incidence and prevalence of Crohn’s disease in an urban population in Germany. Eur J Gastroenterol Hepatol 1994;6:1039–45.
   Web of Science ®Google Scholar
• Loffler A, Glados M. [Data on the epidemiology of Crohn disease in the city of Cologne]. Med Klin (Munich) 1993;88:516–19.
   PubMedGoogle Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785–94.
   PubMed Web of Science ®Google Scholar
• Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 2006;18:601–6.
   PubMed Web of Science ®Google Scholar
• Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266–80.
   PubMed Web of Science ®Google Scholar
• Hoffmann F, Icks A. [Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor]. Gesundheitswesen 2012;74:291–7.
   PubMed Web of Science ®Google Scholar
• Ihle P, Köster I, Herholz H, Rambow-Bertram P, Schardt T, Schubert I. [Sample survey of persons insured in statutory health insurance institutions in Hessen – concept and realisation of person-related data base]. Gesundheitswesen 2005;67:638–45.
   PubMed Web of Science ®Google Scholar
• Deutsches Institut für medizinische Dokumentation und Information (DIMDI). [Code search: ICD-10-GM online enquiry]. 2013. Available from www.dimdi.de/static/de/klassi/icd-10-gm/kodesuche/index.htm. Last accessed 14 August 2013.
   Google Scholar
• Abbas S, Ihle P, Koster I, Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol 2012;160:79–83.
   PubMed Web of Science ®Google Scholar
• Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006;49:1498–504.
   PubMed Web of Science ®Google Scholar
• Schubert I, Köster I, Lehmkuhl G. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007. Dtsch Arztebl Int 2010;107:615–21.
   PubMed Web of Science ®Google Scholar
• Schubert I, Hein R, Abbas S, Thurmann P. The Frequency of Prescription of Immediate-Release Nifedipine for Elderly Patients in Germany: Utilization Analysis of a Substance on the PRISCUS List of Potentially Inappropriate Medications. Dtsch Arztebl Int 2012;109:215–19.
   PubMedGoogle Scholar
• Arbeitsgruppe Erhebung und Nutzen von Sekundärdaten (AGENS) der Deutschen gesellschaft für Sozialmedizin und Prävention (DGSMP) und Arbeitsgruppe Epidemiologische Methoden, der Deutschen Gesellschaft für Epidemiologie (DGEpi), der Deutschen Gesellschaft. [Good practice of secondary data analysis, first revision]. Gesundheitswesen 2008;70:54–60.
   Google Scholar
• Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916–24.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559–68.
   PubMed Web of Science ®Google Scholar
• Büsch K, Ludvigsson JF, Ekstrom-Smedby K, Ekbom A, Askling J, Neovius M. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther 2013;39:57–68.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010;16:112–24.
   PubMed Web of Science ®Google Scholar
• Efron B, Tibshirani RJ. An introduction to the bootstrap. New York & London: CRC Press; 1994.
   Google Scholar
• Fleiss JL, Levin B, Paik MC. Poisson regression. In Balding DJ, Cressie NAC, Fisher NI, et al. editors. Statistical methods for rates and proportions. Hoboken, NJ, USA: John Wiley & Sons, Inc; 2003. p 340–72.
   Google Scholar
• Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2–15.
   PubMed Web of Science ®Google Scholar
• Stallmach A, Häuser W, L’hoest H, Marschall U. [The inflammatory bowel diseases Crohn’s disease and ulcerative colitis: challenges for the health-care provision]. In Repschläger U, Schulte C, Osterkamp N, editors. BARMER GEK die gesund experten; Gesundheitswesen aktuell 2012. Düsseldorf, Germany: 37 Grad GmbH; 2012. p 286–309.
   Google Scholar
• Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013;29:357–62.
   PubMed Web of Science ®Google Scholar
• Juillerat P, Pittet V, Bulliard JL, Guessous I, Antonino AT, Mottet C, et al. Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): a population-based cohort study. J Crohns Colitis 2008;2:131–41.
   PubMed Web of Science ®Google Scholar
• Azevedo LF, Magro F, Portela F, Lago P, Deus J, Cotter J, et al. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach. Pharmacoepidemiol Drug Saf 2010;19:499–510.
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, et al. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007;42:602–10.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–40.
   PubMed Web of Science ®Google Scholar
• Arias-Loste MT, Castro B, Rivero M, Crespo J. Epidemiology of intrafamilial inflammatory bowel disease throughout Europe. Ann Gastroenterol 2012;25:188–92.
   PubMedGoogle Scholar
• Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014;63:588–97.
   PubMed Web of Science ®Google Scholar
• AOK Bundesverband. [Numbers and facts 2012]. 2012. Available from www.aok-bv.de. Last accessed 16 August 2013.
   Google Scholar
• Jaunzeme J, Eberhard S, Geyer S. [How "representative" are SHI (statutory health insurance) data? : Demographic and social differences and similarities between an SHI-insured population, the population of Lower Saxony, and that of the Federal Republic of Germany using the example of the AOK in Lower Saxony.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:447–54.
   PubMed Web of Science ®Google Scholar
• Andersen V, Olsen A, Carbonnel F, Tjonneland A, Vogel U. Diet and risk of inflammatory bowel disease. Dig Liver Dis 2012;44:185–94.
   PubMedGoogle Scholar
• Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006;164:615–23.
   PubMed Web of Science ®Google Scholar
• Haustein KO. Smoking and poverty. Eur J Cardiovasc Prev Rehabil 2006;13:312–18.
   PubMedGoogle Scholar
• Tjora T, Hetland J, Aaro LE, Overland S. Distal and proximal family predictors of adolescents’ smoking initiation and development: a longitudinal latent curve model analysis. BMC Public Health 2011;11:911.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Brensinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002;11:211–18.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Quan H, Fedorak RN, Panaccione R, Hilsden RJ. Development and validation of an administrative case definition for inflammatory bowel diseases. Can J Gastroenterol 2012;26:711–17.
   PubMed Web of Science ®Google Scholar
• Thirumurthi S, Chowdhury R, Richardson P, Abraham NS. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci 2010;55:2592–8.
   PubMed Web of Science ®Google Scholar